ARKG vs. IVV

In the year-to-date period, ARKG achieves a -6.26% return, which is significantly lower than IVV's -0.20% return. Over the past 10 years, ARKG has underperformed IVV with an annualized return of 0.40%, while IVV has yielded a comparatively higher 12.65% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

ARKG has a 0.75% expense ratio, which is higher than IVV's 0.03% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ARKG Sharpe Ratio is -0.25, which is lower than the IVV Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of ARKG and IVV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

ARKG has not paid dividends to shareholders, while IVV's dividend yield for the trailing twelve months is around 1.32%.

The maximum ARKG drawdown since its inception was -83.59%, which is greater than IVV's maximum drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for ARKG and IVV. For additional features, visit the drawdowns tool.

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.88% compared to iShares Core S&P 500 ETF (IVV) at 6.34%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.